Loading…

The Cytokine Profiles and Immune Response Are Increased in COVID-19 Patients with Type 2 Diabetes Mellitus

The induction of inflammation and cytokine storm was proposed to play a critical role in COVID-19. This study is aimed at investigating the relationship between glucose metabolism and the inflammatory state of inpatients with COVID-19. 71 inpatients with COVID-19 were classified into nondiabetes mel...

Full description

Saved in:
Bibliographic Details
Published in:Journal of diabetes research 2021-01, Vol.2021, p.9526701-8
Main Authors: Zheng, Mao, Wang, Xiaobing, Guo, Hui, Fan, Yinguang, Song, Zichen, Lu, Zhaohui, Wang, Jinquan, Zheng, Changcheng, Dong, Lin, Ma, Yan, Zhu, Yuyou, Fang, Haoshu, Ye, Shandong
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c612t-f6c64b3eaa03e0630028dd3e0ef465f5f1f75ebbd42ed82966cd19e4f829f76c3
cites cdi_FETCH-LOGICAL-c612t-f6c64b3eaa03e0630028dd3e0ef465f5f1f75ebbd42ed82966cd19e4f829f76c3
container_end_page 8
container_issue
container_start_page 9526701
container_title Journal of diabetes research
container_volume 2021
creator Zheng, Mao
Wang, Xiaobing
Guo, Hui
Fan, Yinguang
Song, Zichen
Lu, Zhaohui
Wang, Jinquan
Zheng, Changcheng
Dong, Lin
Ma, Yan
Zhu, Yuyou
Fang, Haoshu
Ye, Shandong
description The induction of inflammation and cytokine storm was proposed to play a critical role in COVID-19. This study is aimed at investigating the relationship between glucose metabolism and the inflammatory state of inpatients with COVID-19. 71 inpatients with COVID-19 were classified into nondiabetes mellitus (NDM) group, impaired fasting glucose (IFG) group, and diabetes mellitus (DM) group. The average hospitalization days were significantly shorter in DM patients when compared with patients in the IFG group and NDM group. CD4+ T cell percentage was higher while CD8+ T cells percentage was lower in the DM group than those in the NDM group. The serum levels of IL-6, IL-2, IL-10, and INF-γ in the DM group were upregulated when compared with those in the NDM group. The serum levels of TNF-α, IL-4, IL-2, IL-10, and INF-γ were significantly higher in the DM group than those in the IFG group. A significant difference was observed in CD4+ T cell, CD4+/CD8+ ratio percentage, IL-6, and IL-10 between the NDM group and DM group with adjusted BMI. In conclusion, COVID-19 patients with elevated glucose levels have promoted cytokine profiles and immune response.
doi_str_mv 10.1155/2021/9526701
format article
fullrecord <record><control><sourceid>proquest_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_2fe958a94fe44e509f961c4e504a94c6</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><doaj_id>oai_doaj_org_article_2fe958a94fe44e509f961c4e504a94c6</doaj_id><sourcerecordid>2476482162</sourcerecordid><originalsourceid>FETCH-LOGICAL-c612t-f6c64b3eaa03e0630028dd3e0ef465f5f1f75ebbd42ed82966cd19e4f829f76c3</originalsourceid><addsrcrecordid>eNp9ks1v1DAQxSMEolXpjTOyxAUJQm3HduILUrXlI1JRK7RwtRxn3PWS2IudUO1_j5ddVpQDvvhp_NPTzPgVxXOC3xLC-QXFlFxITkWNyaPilFaElaLm1eOjZvykOE9pjfORlWx487Q4qSomMW2a02K9XAFabKfw3XlAtzFYN0BC2veoHcc5175A2gSfAF1GQK03EXSCHjmPFjff2quSSHSrJwd-SujeTSu03G4AUXTldAdT9voMw-CmOT0rnlg9JDg_3GfF1w_vl4tP5fXNx3ZxeV0aQehUWmEE6yrQGleARYVzo32fJVgmuOWW2JpD1_WMQt9QKYTpiQRms7a1MNVZ0e59-6DXahPdqONWBe3U70KId0rHyZkBFLUgeaMls8AYcCytFMTsFMtFI7LXu73XZu5G6E2eMurhgenDF-9W6i78VHUtRcNkNnh1MIjhxwxpUqNLJm9EewhzUpQ1uK54_rKMvvwHXYc5-ryqTNWCNZQImqk3e8rEkFIEe2yGYLXLhNplQh0ykfEXfw9whP8kIAOv98DK-V7fu__b_QKSbrz0</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2476482162</pqid></control><display><type>article</type><title>The Cytokine Profiles and Immune Response Are Increased in COVID-19 Patients with Type 2 Diabetes Mellitus</title><source>Wiley Online Library Open Access</source><source>Publicly Available Content Database</source><source>PubMed Central</source><source>Coronavirus Research Database</source><creator>Zheng, Mao ; Wang, Xiaobing ; Guo, Hui ; Fan, Yinguang ; Song, Zichen ; Lu, Zhaohui ; Wang, Jinquan ; Zheng, Changcheng ; Dong, Lin ; Ma, Yan ; Zhu, Yuyou ; Fang, Haoshu ; Ye, Shandong</creator><contributor>Goebl, Christian S. ; Christian S Goebl</contributor><creatorcontrib>Zheng, Mao ; Wang, Xiaobing ; Guo, Hui ; Fan, Yinguang ; Song, Zichen ; Lu, Zhaohui ; Wang, Jinquan ; Zheng, Changcheng ; Dong, Lin ; Ma, Yan ; Zhu, Yuyou ; Fang, Haoshu ; Ye, Shandong ; Goebl, Christian S. ; Christian S Goebl</creatorcontrib><description>The induction of inflammation and cytokine storm was proposed to play a critical role in COVID-19. This study is aimed at investigating the relationship between glucose metabolism and the inflammatory state of inpatients with COVID-19. 71 inpatients with COVID-19 were classified into nondiabetes mellitus (NDM) group, impaired fasting glucose (IFG) group, and diabetes mellitus (DM) group. The average hospitalization days were significantly shorter in DM patients when compared with patients in the IFG group and NDM group. CD4+ T cell percentage was higher while CD8+ T cells percentage was lower in the DM group than those in the NDM group. The serum levels of IL-6, IL-2, IL-10, and INF-γ in the DM group were upregulated when compared with those in the NDM group. The serum levels of TNF-α, IL-4, IL-2, IL-10, and INF-γ were significantly higher in the DM group than those in the IFG group. A significant difference was observed in CD4+ T cell, CD4+/CD8+ ratio percentage, IL-6, and IL-10 between the NDM group and DM group with adjusted BMI. In conclusion, COVID-19 patients with elevated glucose levels have promoted cytokine profiles and immune response.</description><identifier>ISSN: 2314-6745</identifier><identifier>EISSN: 2314-6753</identifier><identifier>DOI: 10.1155/2021/9526701</identifier><identifier>PMID: 33490288</identifier><language>eng</language><publisher>England: Hindawi</publisher><subject>Adult ; Aged ; Biomarkers - blood ; Blood Glucose - metabolism ; Body mass index ; CD4-Positive T-Lymphocytes - immunology ; CD4-Positive T-Lymphocytes - metabolism ; CD4-Positive T-Lymphocytes - virology ; CD8-Positive T-Lymphocytes - immunology ; CD8-Positive T-Lymphocytes - metabolism ; CD8-Positive T-Lymphocytes - virology ; Coronaviruses ; COVID-19 ; COVID-19 - blood ; COVID-19 - epidemiology ; COVID-19 - immunology ; COVID-19 - virology ; Cytokine storm ; Cytokines - blood ; Cytokines - immunology ; Diabetes ; Diabetes Mellitus, Type 2 - blood ; Diabetes Mellitus, Type 2 - epidemiology ; Diabetes Mellitus, Type 2 - immunology ; Drugs ; Female ; Glucose ; Host-Pathogen Interactions ; Humans ; Illnesses ; Inflammation Mediators - blood ; Inflammation Mediators - immunology ; Insulin ; Laboratories ; Length of Stay ; Male ; Metabolism ; Middle Aged ; Mortality ; Pandemics ; Patients ; Prognosis ; Reagents ; Respiratory diseases ; SARS-CoV-2 - immunology ; Sepsis ; Severe acute respiratory syndrome coronavirus 2 ; Time Factors</subject><ispartof>Journal of diabetes research, 2021-01, Vol.2021, p.9526701-8</ispartof><rights>Copyright © 2021 Mao Zheng et al.</rights><rights>Copyright © 2021 Mao Zheng et al. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>Copyright © 2021 Mao Zheng et al. 2021</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c612t-f6c64b3eaa03e0630028dd3e0ef465f5f1f75ebbd42ed82966cd19e4f829f76c3</citedby><cites>FETCH-LOGICAL-c612t-f6c64b3eaa03e0630028dd3e0ef465f5f1f75ebbd42ed82966cd19e4f829f76c3</cites><orcidid>0000-0001-5512-9846 ; 0000-0002-6079-299X ; 0000-0003-2580-8949 ; 0000-0001-9278-8007 ; 0000-0002-5491-7418 ; 0000-0003-3108-6305 ; 0000-0002-9155-4150</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.proquest.com/docview/2476482162?pq-origsite=primo$$EPDF$$P50$$Gproquest$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/2476482162?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>230,314,723,776,780,881,25731,27901,27902,36989,36990,38493,43871,44566,53766,53768,74155,74869</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/33490288$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><contributor>Goebl, Christian S.</contributor><contributor>Christian S Goebl</contributor><creatorcontrib>Zheng, Mao</creatorcontrib><creatorcontrib>Wang, Xiaobing</creatorcontrib><creatorcontrib>Guo, Hui</creatorcontrib><creatorcontrib>Fan, Yinguang</creatorcontrib><creatorcontrib>Song, Zichen</creatorcontrib><creatorcontrib>Lu, Zhaohui</creatorcontrib><creatorcontrib>Wang, Jinquan</creatorcontrib><creatorcontrib>Zheng, Changcheng</creatorcontrib><creatorcontrib>Dong, Lin</creatorcontrib><creatorcontrib>Ma, Yan</creatorcontrib><creatorcontrib>Zhu, Yuyou</creatorcontrib><creatorcontrib>Fang, Haoshu</creatorcontrib><creatorcontrib>Ye, Shandong</creatorcontrib><title>The Cytokine Profiles and Immune Response Are Increased in COVID-19 Patients with Type 2 Diabetes Mellitus</title><title>Journal of diabetes research</title><addtitle>J Diabetes Res</addtitle><description>The induction of inflammation and cytokine storm was proposed to play a critical role in COVID-19. This study is aimed at investigating the relationship between glucose metabolism and the inflammatory state of inpatients with COVID-19. 71 inpatients with COVID-19 were classified into nondiabetes mellitus (NDM) group, impaired fasting glucose (IFG) group, and diabetes mellitus (DM) group. The average hospitalization days were significantly shorter in DM patients when compared with patients in the IFG group and NDM group. CD4+ T cell percentage was higher while CD8+ T cells percentage was lower in the DM group than those in the NDM group. The serum levels of IL-6, IL-2, IL-10, and INF-γ in the DM group were upregulated when compared with those in the NDM group. The serum levels of TNF-α, IL-4, IL-2, IL-10, and INF-γ were significantly higher in the DM group than those in the IFG group. A significant difference was observed in CD4+ T cell, CD4+/CD8+ ratio percentage, IL-6, and IL-10 between the NDM group and DM group with adjusted BMI. In conclusion, COVID-19 patients with elevated glucose levels have promoted cytokine profiles and immune response.</description><subject>Adult</subject><subject>Aged</subject><subject>Biomarkers - blood</subject><subject>Blood Glucose - metabolism</subject><subject>Body mass index</subject><subject>CD4-Positive T-Lymphocytes - immunology</subject><subject>CD4-Positive T-Lymphocytes - metabolism</subject><subject>CD4-Positive T-Lymphocytes - virology</subject><subject>CD8-Positive T-Lymphocytes - immunology</subject><subject>CD8-Positive T-Lymphocytes - metabolism</subject><subject>CD8-Positive T-Lymphocytes - virology</subject><subject>Coronaviruses</subject><subject>COVID-19</subject><subject>COVID-19 - blood</subject><subject>COVID-19 - epidemiology</subject><subject>COVID-19 - immunology</subject><subject>COVID-19 - virology</subject><subject>Cytokine storm</subject><subject>Cytokines - blood</subject><subject>Cytokines - immunology</subject><subject>Diabetes</subject><subject>Diabetes Mellitus, Type 2 - blood</subject><subject>Diabetes Mellitus, Type 2 - epidemiology</subject><subject>Diabetes Mellitus, Type 2 - immunology</subject><subject>Drugs</subject><subject>Female</subject><subject>Glucose</subject><subject>Host-Pathogen Interactions</subject><subject>Humans</subject><subject>Illnesses</subject><subject>Inflammation Mediators - blood</subject><subject>Inflammation Mediators - immunology</subject><subject>Insulin</subject><subject>Laboratories</subject><subject>Length of Stay</subject><subject>Male</subject><subject>Metabolism</subject><subject>Middle Aged</subject><subject>Mortality</subject><subject>Pandemics</subject><subject>Patients</subject><subject>Prognosis</subject><subject>Reagents</subject><subject>Respiratory diseases</subject><subject>SARS-CoV-2 - immunology</subject><subject>Sepsis</subject><subject>Severe acute respiratory syndrome coronavirus 2</subject><subject>Time Factors</subject><issn>2314-6745</issn><issn>2314-6753</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><sourceid>COVID</sourceid><sourceid>PIMPY</sourceid><sourceid>DOA</sourceid><recordid>eNp9ks1v1DAQxSMEolXpjTOyxAUJQm3HduILUrXlI1JRK7RwtRxn3PWS2IudUO1_j5ddVpQDvvhp_NPTzPgVxXOC3xLC-QXFlFxITkWNyaPilFaElaLm1eOjZvykOE9pjfORlWx487Q4qSomMW2a02K9XAFabKfw3XlAtzFYN0BC2veoHcc5175A2gSfAF1GQK03EXSCHjmPFjff2quSSHSrJwd-SujeTSu03G4AUXTldAdT9voMw-CmOT0rnlg9JDg_3GfF1w_vl4tP5fXNx3ZxeV0aQehUWmEE6yrQGleARYVzo32fJVgmuOWW2JpD1_WMQt9QKYTpiQRms7a1MNVZ0e59-6DXahPdqONWBe3U70KId0rHyZkBFLUgeaMls8AYcCytFMTsFMtFI7LXu73XZu5G6E2eMurhgenDF-9W6i78VHUtRcNkNnh1MIjhxwxpUqNLJm9EewhzUpQ1uK54_rKMvvwHXYc5-ryqTNWCNZQImqk3e8rEkFIEe2yGYLXLhNplQh0ykfEXfw9whP8kIAOv98DK-V7fu__b_QKSbrz0</recordid><startdate>20210102</startdate><enddate>20210102</enddate><creator>Zheng, Mao</creator><creator>Wang, Xiaobing</creator><creator>Guo, Hui</creator><creator>Fan, Yinguang</creator><creator>Song, Zichen</creator><creator>Lu, Zhaohui</creator><creator>Wang, Jinquan</creator><creator>Zheng, Changcheng</creator><creator>Dong, Lin</creator><creator>Ma, Yan</creator><creator>Zhu, Yuyou</creator><creator>Fang, Haoshu</creator><creator>Ye, Shandong</creator><general>Hindawi</general><general>Hindawi Limited</general><scope>RHU</scope><scope>RHW</scope><scope>RHX</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7RV</scope><scope>7X7</scope><scope>7XB</scope><scope>8C1</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>COVID</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>KB0</scope><scope>M0S</scope><scope>M0T</scope><scope>NAPCQ</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope><orcidid>https://orcid.org/0000-0001-5512-9846</orcidid><orcidid>https://orcid.org/0000-0002-6079-299X</orcidid><orcidid>https://orcid.org/0000-0003-2580-8949</orcidid><orcidid>https://orcid.org/0000-0001-9278-8007</orcidid><orcidid>https://orcid.org/0000-0002-5491-7418</orcidid><orcidid>https://orcid.org/0000-0003-3108-6305</orcidid><orcidid>https://orcid.org/0000-0002-9155-4150</orcidid></search><sort><creationdate>20210102</creationdate><title>The Cytokine Profiles and Immune Response Are Increased in COVID-19 Patients with Type 2 Diabetes Mellitus</title><author>Zheng, Mao ; Wang, Xiaobing ; Guo, Hui ; Fan, Yinguang ; Song, Zichen ; Lu, Zhaohui ; Wang, Jinquan ; Zheng, Changcheng ; Dong, Lin ; Ma, Yan ; Zhu, Yuyou ; Fang, Haoshu ; Ye, Shandong</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c612t-f6c64b3eaa03e0630028dd3e0ef465f5f1f75ebbd42ed82966cd19e4f829f76c3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Adult</topic><topic>Aged</topic><topic>Biomarkers - blood</topic><topic>Blood Glucose - metabolism</topic><topic>Body mass index</topic><topic>CD4-Positive T-Lymphocytes - immunology</topic><topic>CD4-Positive T-Lymphocytes - metabolism</topic><topic>CD4-Positive T-Lymphocytes - virology</topic><topic>CD8-Positive T-Lymphocytes - immunology</topic><topic>CD8-Positive T-Lymphocytes - metabolism</topic><topic>CD8-Positive T-Lymphocytes - virology</topic><topic>Coronaviruses</topic><topic>COVID-19</topic><topic>COVID-19 - blood</topic><topic>COVID-19 - epidemiology</topic><topic>COVID-19 - immunology</topic><topic>COVID-19 - virology</topic><topic>Cytokine storm</topic><topic>Cytokines - blood</topic><topic>Cytokines - immunology</topic><topic>Diabetes</topic><topic>Diabetes Mellitus, Type 2 - blood</topic><topic>Diabetes Mellitus, Type 2 - epidemiology</topic><topic>Diabetes Mellitus, Type 2 - immunology</topic><topic>Drugs</topic><topic>Female</topic><topic>Glucose</topic><topic>Host-Pathogen Interactions</topic><topic>Humans</topic><topic>Illnesses</topic><topic>Inflammation Mediators - blood</topic><topic>Inflammation Mediators - immunology</topic><topic>Insulin</topic><topic>Laboratories</topic><topic>Length of Stay</topic><topic>Male</topic><topic>Metabolism</topic><topic>Middle Aged</topic><topic>Mortality</topic><topic>Pandemics</topic><topic>Patients</topic><topic>Prognosis</topic><topic>Reagents</topic><topic>Respiratory diseases</topic><topic>SARS-CoV-2 - immunology</topic><topic>Sepsis</topic><topic>Severe acute respiratory syndrome coronavirus 2</topic><topic>Time Factors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Zheng, Mao</creatorcontrib><creatorcontrib>Wang, Xiaobing</creatorcontrib><creatorcontrib>Guo, Hui</creatorcontrib><creatorcontrib>Fan, Yinguang</creatorcontrib><creatorcontrib>Song, Zichen</creatorcontrib><creatorcontrib>Lu, Zhaohui</creatorcontrib><creatorcontrib>Wang, Jinquan</creatorcontrib><creatorcontrib>Zheng, Changcheng</creatorcontrib><creatorcontrib>Dong, Lin</creatorcontrib><creatorcontrib>Ma, Yan</creatorcontrib><creatorcontrib>Zhu, Yuyou</creatorcontrib><creatorcontrib>Fang, Haoshu</creatorcontrib><creatorcontrib>Ye, Shandong</creatorcontrib><collection>Hindawi Publishing Complete</collection><collection>Hindawi Publishing Subscription Journals</collection><collection>Hindawi Publishing Open Access Journals</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Nursing &amp; Allied Health Database</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Public Health Database</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Coronavirus Research Database</collection><collection>ProQuest Central</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Database (Alumni Edition)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Healthcare Administration Database</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>Journal of diabetes research</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Zheng, Mao</au><au>Wang, Xiaobing</au><au>Guo, Hui</au><au>Fan, Yinguang</au><au>Song, Zichen</au><au>Lu, Zhaohui</au><au>Wang, Jinquan</au><au>Zheng, Changcheng</au><au>Dong, Lin</au><au>Ma, Yan</au><au>Zhu, Yuyou</au><au>Fang, Haoshu</au><au>Ye, Shandong</au><au>Goebl, Christian S.</au><au>Christian S Goebl</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The Cytokine Profiles and Immune Response Are Increased in COVID-19 Patients with Type 2 Diabetes Mellitus</atitle><jtitle>Journal of diabetes research</jtitle><addtitle>J Diabetes Res</addtitle><date>2021-01-02</date><risdate>2021</risdate><volume>2021</volume><spage>9526701</spage><epage>8</epage><pages>9526701-8</pages><issn>2314-6745</issn><eissn>2314-6753</eissn><abstract>The induction of inflammation and cytokine storm was proposed to play a critical role in COVID-19. This study is aimed at investigating the relationship between glucose metabolism and the inflammatory state of inpatients with COVID-19. 71 inpatients with COVID-19 were classified into nondiabetes mellitus (NDM) group, impaired fasting glucose (IFG) group, and diabetes mellitus (DM) group. The average hospitalization days were significantly shorter in DM patients when compared with patients in the IFG group and NDM group. CD4+ T cell percentage was higher while CD8+ T cells percentage was lower in the DM group than those in the NDM group. The serum levels of IL-6, IL-2, IL-10, and INF-γ in the DM group were upregulated when compared with those in the NDM group. The serum levels of TNF-α, IL-4, IL-2, IL-10, and INF-γ were significantly higher in the DM group than those in the IFG group. A significant difference was observed in CD4+ T cell, CD4+/CD8+ ratio percentage, IL-6, and IL-10 between the NDM group and DM group with adjusted BMI. In conclusion, COVID-19 patients with elevated glucose levels have promoted cytokine profiles and immune response.</abstract><cop>England</cop><pub>Hindawi</pub><pmid>33490288</pmid><doi>10.1155/2021/9526701</doi><tpages>8</tpages><orcidid>https://orcid.org/0000-0001-5512-9846</orcidid><orcidid>https://orcid.org/0000-0002-6079-299X</orcidid><orcidid>https://orcid.org/0000-0003-2580-8949</orcidid><orcidid>https://orcid.org/0000-0001-9278-8007</orcidid><orcidid>https://orcid.org/0000-0002-5491-7418</orcidid><orcidid>https://orcid.org/0000-0003-3108-6305</orcidid><orcidid>https://orcid.org/0000-0002-9155-4150</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 2314-6745
ispartof Journal of diabetes research, 2021-01, Vol.2021, p.9526701-8
issn 2314-6745
2314-6753
language eng
recordid cdi_doaj_primary_oai_doaj_org_article_2fe958a94fe44e509f961c4e504a94c6
source Wiley Online Library Open Access; Publicly Available Content Database; PubMed Central; Coronavirus Research Database
subjects Adult
Aged
Biomarkers - blood
Blood Glucose - metabolism
Body mass index
CD4-Positive T-Lymphocytes - immunology
CD4-Positive T-Lymphocytes - metabolism
CD4-Positive T-Lymphocytes - virology
CD8-Positive T-Lymphocytes - immunology
CD8-Positive T-Lymphocytes - metabolism
CD8-Positive T-Lymphocytes - virology
Coronaviruses
COVID-19
COVID-19 - blood
COVID-19 - epidemiology
COVID-19 - immunology
COVID-19 - virology
Cytokine storm
Cytokines - blood
Cytokines - immunology
Diabetes
Diabetes Mellitus, Type 2 - blood
Diabetes Mellitus, Type 2 - epidemiology
Diabetes Mellitus, Type 2 - immunology
Drugs
Female
Glucose
Host-Pathogen Interactions
Humans
Illnesses
Inflammation Mediators - blood
Inflammation Mediators - immunology
Insulin
Laboratories
Length of Stay
Male
Metabolism
Middle Aged
Mortality
Pandemics
Patients
Prognosis
Reagents
Respiratory diseases
SARS-CoV-2 - immunology
Sepsis
Severe acute respiratory syndrome coronavirus 2
Time Factors
title The Cytokine Profiles and Immune Response Are Increased in COVID-19 Patients with Type 2 Diabetes Mellitus
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-30T00%3A20%3A05IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20Cytokine%20Profiles%20and%20Immune%20Response%20Are%20Increased%20in%20COVID-19%20Patients%20with%20Type%202%20Diabetes%20Mellitus&rft.jtitle=Journal%20of%20diabetes%20research&rft.au=Zheng,%20Mao&rft.date=2021-01-02&rft.volume=2021&rft.spage=9526701&rft.epage=8&rft.pages=9526701-8&rft.issn=2314-6745&rft.eissn=2314-6753&rft_id=info:doi/10.1155/2021/9526701&rft_dat=%3Cproquest_doaj_%3E2476482162%3C/proquest_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c612t-f6c64b3eaa03e0630028dd3e0ef465f5f1f75ebbd42ed82966cd19e4f829f76c3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2476482162&rft_id=info:pmid/33490288&rfr_iscdi=true